AGC Biologics Supports Altheia Science’s Gene Therapy Programs
28 juil. 2022 08h00 HE
|
AGC Biologics
SEATTLE, MILAN, July 28, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with...
Global Viral Vectors and Plasmid DNA Manufacturing Market is anticipated to reach US$2,381.5 Million in 2031: Visiongain Research Inc
23 mars 2022 10h00 HE
|
Visiongain Ltd
Visiongain has published a new report on “Viral Vectors and Plasmid DNA Manufacturing Market 2021-2031”. Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus,...
Viral Vectors and Plasmid DNA Manufacturing Market size worth $ 1,866.90 Million, Globally, by 2028 at 15.40% CAGR: Verified Market Research®
26 oct. 2021 11h15 HE
|
Verified Market Research
Jersey City, New Jersey, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “Viral Vectors and Plasmid DNA Manufacturing Market” By Product Type (Viral Vectors,...
Viral Vectors & Plasmid DNA Manufacturing Market to Hit US$ 1.3 Bn by 2027
19 août 2021 11h00 HE
|
Precedence Research
Ottawa, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Ottawa, Aug 19, 2021 (GLOBE NEWSWIRE) – According to Precedence Research, the viral vectors & plasmid DNA manufacturing market size was valued at US$...
Viral Vectors and Plasmid DNA Manufacturing Market Worth US$2,381.5 Million by 2031: Visiongain Research Inc.
07 juil. 2021 09h00 HE
|
Visiongain Ltd
Visiongain has published a new report on “Viral Vectors and Plasmid DNA Manufacturing Market 2021-2031”. Forecasts by Vector Type (Adenovirus, Retrovirus, Plasmid DNA, AAV, Lentivirus, Others),...
Viral Vectors and Plasmid DNA Manufacturing Market to Garner $4.97 Billion by 2027: AMR
13 oct. 2020 09h38 HE
|
Allied Market Research
Portland, OR, Oct. 13, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global viral vectors and plasmid DNA manufacturing market generated $918.37 million in...
Viral Vectors & Plasmid DNA Manufacturing Market Size is Expanding over US$ 1.3 Bn by 2027
30 sept. 2020 11h45 HE
|
Precedence Research
The global viral vectors & plasmid DNA manufacturing market size is expanding over US$ 1.3 billion by 2027, according to new study by Precedence Research. OTTAWA, Sept. 30, 2020 (GLOBE...
Toronto centre solving cell manufacturing challenges to benefit patients and global industry
02 juin 2020 06h00 HE
|
Centre for Commercialization of Regenerative Medicine (CCRM)
TORONTO and MARLBOROUGH, Mass., June 02, 2020 (GLOBE NEWSWIRE) -- With Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant...